Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world Study

CompletedOBSERVATIONAL

Enrollment

826

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

May 31, 2022

Study Completion Date

February 8, 2023

Conditions

Hepatocellular Carcinoma

Interventions

OTHER

TACE+ICIs

TACE plus ICIs ( with or without molecular targeted therapies)

PROCEDURE

TACE

TACE without combination of ICIs ( with or without molecular targeted therapies)

Trial Locations (1)

Gao-Jun Teng, Nanjing

All Listed Sponsors

lead

Zhongda Hospital

OTHER